Article
Multi-omic profiling of breast cancer cells uncovers stress MAPK-associated sensitivity to AKT degradation
2022-10-11
Abstract excerpt
Over 50% of human tumors display hyperactivation of the serine/threonine kinase AKT. Despite evidence of clinical efficacy, there remains scope to improve upon the therapeutic window of the current generation of AKT inhibitors. Here we report the development of a second-generation AKT degrader, INY-05-040, which outperformed catalytic AKT inhibition with respect to cellular suppression of AKT-driven phenotypes in...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 7e3a9771-d5f4-521d-8d1c-a43b82dee12e
- DOI
- 10.1101/2022.10.11.511726
